摘要
目的:探讨目前混合性肝癌的诊疗策略及进展。方法:回顾性分析2020年11月青岛大学附属医院肝胆外科收治1例混合性肝癌患者的临床特征、实验室检查指标、诊疗经过及治疗转归,并结合相关文献复习展开讨论。结果:患者女,53岁,因原发性肝恶性肿瘤入院,完整肿瘤切除后早期复发(6月),经全身治疗获得二次手术机会,术后随访6月无复发。结论:混合性肝癌由于其肿瘤特性以及其低发病率,目前暂无明确的诊治指导方案,个体化的分阶段治疗可能使患者获益。
Objective: To explore the diagnosis and treatment strategy and progress of mixed liver cancer. Methods: The clinical characteristics, laboratory examination indexes, diagnosis and treatment process and treatment outcome of a patient with mixed liver cancer admitted to the Department of Hepatobiliary Surgery of the Affiliated Hospital of Qingdao University in November 2020 were ana-lyzed retrospectively, and the related literature was reviewed for discussion. Results: A 53-year-old female patient was admitted to the hospital for primary hepatic malignant tumor. The complete tumor recurred early after resection (6 months). After systemic treatment, she received a second operation opportunity. There was no recurrence after 6 months of follow-up. Conclusion: Because of its tumor characteristics and low incidence rate, there is no clear diagnosis and treatment guidance plan for mixed liver cancer at present. Individualized phased treatment may benefit patients.
出处
《临床医学进展》
2023年第1期824-830,共7页
Advances in Clinical Medicine
